|
|
Blood, 1 December 2005, Vol. 106, No. 12, pp. 3860-3866.
Prepublished online as a Blood First Edition Paper on August 23, 2005; DOI 10.1182/blood-2005-05-1843.
Previous Article | Next Article 
Submitted May 6, 2005
Accepted August 2, 2005
Thrombospondin-1 and indoleamine 2,3-dioxygenase are major targets of extracellular ATP in human dendritic cells
Frederic Marteau, Nathalie Suarez Gonzalez, David Communi, Michel Goldman, Jean-Marie Boeynaems, and Didier Communi*
Institute of Interdisciplinary Research, IRIBHM, Universite Libre de Bruxelles, Brussels, Belgium
Institute for Medical Immunology, IMI, Universite Libre de Bruxelles, Gosselies, Belgium
Institute of Interdisciplinary Research, IRIBHM, Universite Libre de Bruxelles, Brussels, Belgium; Department of Medical Chemistry, Erasme Hospital, Universite Libre de Bruxelles, Brussels, Belgium
* Corresponding author; email: communid{at}ulb.ac.be.
Extracellular adenosine triphosphate affects the maturation of human monocyte-derived dendritic cells (DCs), mainly by inhibiting Th1 cytokines, promoting Th2 cytokines, and modulating the expression of costimulatory molecules. In this study, we report that ATP can induce immunosuppression through its action on DCs defining a new role for extracellular nucleotides. Microarray analysis of ATP-stimulated human DCs revealed inter alia a drastic up-regulation of two genes encoding mediators involved in immunosuppression: thrombospondin-1 (TSP-1) and indoleamine 2,3-dioxygenase (IDO). The release of TSP-1 by DCs in response to ATP was confirmed at the protein level by ELISA, immunodetection and mass spectrometry analysis and has an anti-proliferative effect on T CD4+ lymphocytes through TSP-1/CD47 interaction. Our pharmacological data support the involvement of P2Y11 receptor in this ATP-mediated TSP-1 secretion. We demonstrate also that ATP significantly potentiates the up-regulation of IDO - a negative regulator of T lymphocyte proliferation - and kynurenine production initiated by IFN- in human DCs. Thus, extracellular ATP released from damaged cells and previously considered as danger signal is also a potent regulator of mediators playing key roles in immune tolerance. Consequently nucleotides derivatives may be considered as useful tools for DC-based immunotherapies.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M.-C. Yen, C.-C. Lin, Y.-L. Chen, S.-S. Huang, H.-J. Yang, C.-P. Chang, H.-Y. Lei, and M.-D. Lai
A Novel Cancer Therapy by Skin Delivery of Indoleamine 2,3-Dioxygenase siRNA
Clin. Cancer Res.,
January 15, 2009;
15(2):
641 - 649.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Shin, T. Toy, S. Rothenfusser, N. Robson, J. Vorac, M. Dauer, M. Stuplich, S. Endres, J. Cebon, E. Maraskovsky, et al.
P2Y receptor signaling regulates phenotype and IFN-{alpha} secretion of human plasmacytoid dendritic cells
Blood,
March 15, 2008;
111(6):
3062 - 3069.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kleinewietfeld, D. DiMitri, A. Sternjak, A. Diamantini, G. Borsellino, L. Battistini, O. Rotzschke, and K. Falk
Hydrolysis of extracellular ATP by CD39+ Treg cells: context matters!
Blood,
January 15, 2008;
111(2):
965 - 966.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Gorini and A. la Sala
Hydrolysis of extracellular ATP and immune suppression: humans versus mice
Blood,
January 15, 2008;
111(2):
964 - 965.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Derks, E. Jankowska-Gan, Q. Xu, and W. J. Burlingham
Dendritic Cell Type Determines the Mechanism of Bystander Suppression by Adaptive T Regulatory Cells Specific for the Minor Antigen HA-1
J. Immunol.,
September 15, 2007;
179(6):
3443 - 3451.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Bles, M. Horckmans, A. Lefort, F. Libert, P. Macours, H. El Housni, F. Marteau, J.-M. Boeynaems, and D. Communi
Gene Expression Profiling Defines ATP as a Key Regulator of Human Dendritic Cell Functions
J. Immunol.,
September 15, 2007;
179(6):
3550 - 3558.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Amisten, O. Melander, A.-K. Wihlborg, G. Berglund, and D. Erlinge
Increased risk of acute myocardial infarction and elevated levels of C-reactive protein in carriersof the Thr-87 variant of the ATP receptor P2Y11
Eur. Heart J.,
January 1, 2007;
28(1):
13 - 18.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. Abbracchio, G. Burnstock, J.-M. Boeynaems, E. A. Barnard, J. L. Boyer, C. Kennedy, G. E. Knight, M. Fumagalli, C. Gachet, K. A. Jacobson, et al.
International Union of Pharmacology LVIII: Update on the P2Y G Protein-Coupled Nucleotide Receptors: From Molecular Mechanisms and Pathophysiology to Therapy
Pharmacol. Rev.,
September 1, 2006;
58(3):
281 - 341.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|